COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,913 Articles (22,044 medRxiv, 7,869 bioRxiv)

Most recent first Previous |  Page 64: Articles 631-640  | Next

A Spike Trimer Dimer-Inducing Nanobody with Anti-Sarbecovirus Activity
Swart, I. C., Debski Antoniak, O. J., Zegar, A., de Bouter, T., Chatziandreou, M., van den Berg, M., Drulyte, I., Pyrc, K., de Haan, C. A. M., Hurdiss, D. L., Bosch, B.-J., Oliveira, S.
10.1101/2024.06.19.598823 — Posted: 2024-06-19
The effect of circulating neutralizing antibodies on the replication of SARS-CoV-2 variants following post-vaccination infections.
Knight, M. A. G., Kelly, J. D., Lu, S., Tassetto, M. A., Goldberg, S. A., Zhang, A., Pineda-Ramirez, J., Anglin, K., Davidson, M., Chen, J. Y., Fortes-Cobby, M., Park, S., Martinez, A., So, M., Donovan, A., Viswanathan, B., Richardson, E. T., McIlwain, D. R., Gaudilliere, B., Rutishauser, R. L., Chenna, A., Petropoulos, C., Wrin, T., Deeks, S., Abedi, G., Saydah, S., Martin, J., Briggs-Hagen, M., Midgley, C. M., Peluso, M., Andino, R.
10.1101/2024.06.18.599357 — Posted: 2024-06-19
Enhancing Blood Availability in Latin America: A Study on Public Perceptions and Barriers to Blood Donation in Guatemala during the COVID-19 Pandemic
Torres Perez-Iglesias, C., Monzon, J., Faria, I., Kundu, S., Zil-E-Ali, A., Jhunjhunwala, R., Raykat, N., Asturias, S.
10.1101/2024.06.16.24309008 — Posted: 2024-06-18
Emergence of transmissible SARS-CoV-2 variants with decreased sensitivity to antivirals in immunocompromised patients with persistent infections
Nooruzzaman, M., Johnson, K. E. E., Rani, R., Finkelsztein, E. J., Caserta, L. C., Kodiyanplakkal, R. P., Wang, W., Hsu, J., Salpietro, M. T., Banakis, S., Albert, J., Westblade, L., Zanettini, C., Marchionni, L., Soave, R., Ghedin, E., Diel, D., Salvatore, M.
10.1101/2024.06.14.24308523 — Posted: 2024-06-18
A Coronaviral Pore-Replicase Complex Drives RNA Synthesis in Double Membrane Vesicles
Chen, A., Lupan, A.-M., Quek, R. T., Stanciu, S. G., Asaftei, M., Stanciu, G. A., Hardy, K., Magalhaes, T., Silver, P. A., Mitchison, T., Salic, A.
10.1101/2024.06.18.599549 — Posted: 2024-06-18
Systems Modeling Reveals Shared Metabolic Dysregulation and Novel Therapeutic Treatments in ME/CFS and Long COVID
Li, G.-H., Han, F., Kong, Q.-P., Xiao, W.
10.1101/2024.06.17.599450 — Posted: 2024-06-18
The differential effect of SARS-COV-2 NSP1 on mRNA translation and stability reveals new insights linking ribosome recruitment, codon usage and virus evolution
Berlanga, J. J., Matamoros, T., Rodriguez Pulido, M., Saiz, M., Nunez Bayon, M., Toribio, R., Ventoso, I.
10.1101/2024.06.17.599344 — Posted: 2024-06-17
TRIM7 ubiquitinates SARS-CoV-2 membrane protein to limit apoptosis and viral replication
Gonzalez-Orozco, M., Tseng, H.-c., Hage, A., Xia, H., Behera, P., Afreen, K., Penaflor-Tellez, Y., Giraldo, M. I., Huante, M., Puebla-Clark, L., van Tol, S., Odle, A., Crown, M., Teruel, N., Shelite, T. R., Menachery, V., Endsley, M., Endsley, J. J., Najmanovich, R. J., Bashton, M., Stephens, R., Shi, P.-Y., Xie, X., Freiberg, A. N., Rajsbaum, R.
10.1101/2024.06.17.599107 — Posted: 2024-06-17
Comparison of three tiled amplicon sequencing approaches for SARS-CoV-2 variant detection from wastewater
Lott, M. E., Sullivan, A. H., Lariscy, L. M., Norfolk, W. A., Dillon, K. C., Beaudry, M. S., Glenn, T. C., Lipp, E. K.
10.1101/2024.06.16.599198 — Posted: 2024-06-17
Near Real-Time Measures of Interregional Mobility Restrictions on COVID-19 Transmission
Berrios, J., Marin Flores, C., Gutierrez, B., Bravo, L., Ferres, L.
10.1101/2024.06.14.24308359 — Posted: 2024-06-17

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).